Can Scenesse be used for vitiligo treatment?

The drug Scenesse from Clinuvel has been tested in clinical trials for vitiligo, in combination with narrowband UVB. The new drug acts as an anti-oxidant and activates melanin in skin, which in turn increases pigmentation of the skin.

Researchers noticed faster and better repigmentation in experimental group compared to the control group receiving only NB-UVB, yet this effect was limited to dark skin types (type IV-VI) but not for type III skin or lighter.

Each 16 mg implant costs around $6,200 and lasts 60 days.

image description

I support the petition to designate June 25 as Vitiligo World Day and save millions of people worldwide from social isolation and persecution.

To download this free file, please tell us a little bit about yourself.